Zyversa Therapeutics Eulerpool Novinky

Zyversa Therapeutics Eulerpool News

Zyversa Therapeutics Novinky o akciách

Zyversa Therapeutics sledujú mnohí novinári a investori po celom svete. Najaktuálnejšie správy Zyversa Therapeutics zhromažďujeme práve tu.

• 3. septembra ·

  Seeking Alpha
  ZyVersa Therapeutics files for mixed shelf offering
• 3. septembra ·

  Thefly.com
  ZyVersa Therapeutics files $100M mixed securities shelf
• 9. augusta ·

  Yahoo
  ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
• 9. augusta ·

  InvestorPlace
  ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024
• 9. augusta ·

  Seeking Alpha
  ZyVersa Therapeutics GAAP EPS of -$3.31 beats by $0.44
• 7. augusta ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
• 7. augusta ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on extracellular ASC
• 29. júla ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
• 29. júla ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on inflammasome ASC
• 25. júla ·

  Yahoo
  ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100